From: Clozapine: a review of clinical practice guidelines and prescribing trends
Date | Source | Recommendation: clozapine to be prescribed or offered to patients | Â | Â |
---|---|---|---|---|
 |  | After failure of 2 adequate trials of 2 different AAs | With suicidal thoughts or behaviours | With persistent hostility and violent behaviours |
2004 | APA (US) [13] | X | Â | Â |
2005 | CPA (CAN) [14] | X | Â | Â |
2007 | TMAP (US) [15] | X (SGAs considered first-line) | Â | Â |
2009 | NICE (UK) [16] | X (at least one of the drugs should be a non-clozapine SGA) | Â | Â |
2010 | Schizophrenia PORT (US) [17] | X | X | X |
2010 | CADTH [18] | X | Â | Â |
2011 | BAP (UK) [19] | X | Â | X |
2013 | PAP (US) [20] | X (SGA, risperidone and olanzapine) considered first-line) | X | X |